| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
| mRNA |
vorapaxar |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
| mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
| mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
| mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
| mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
| mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.8 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |